Effects of supplementation with different Mg salts in cells: Is there a clue?

Magnesium Research

Volumn 27, Issue 1, 2014, Pages 25-34

  Farruggia, Giovanna ^a,b   Castiglioni, Sara ^c   Sargenti, Azzurra ^a   Marraccini, Chiara ^d   Cazzaniga, Alessandra ^c   Merolle, Lucia ^a   Iotti, Stefano ^a,b   Cappadone, Concettina ^a   Maier, Jeanette Anne Marie ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cell proliferation; Intracellular calcium; Intracellular magnesium; Magnesium pidolate

Indexed keywords

CALCIUM ION; ENDOTHELIAL CELL GROWTH FACTOR; FURA 2 ACETOXYMETHYL ESTER; MAGNESIUM CHLORIDE; MAGNESIUM ION; MAGNESIUM SULFATE; PYROGLUTAMATE MAGNESIUM; CALCIUM; INORGANIC SALT; MAGNESIUM; PYROGLUTAMIC ACID;

ARTICLE; CALCIUM CELL LEVEL; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GROWTH CURVE; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; NUTRITIONAL SUPPORT; SPECTROFLUOROMETRY; UMBILICAL VEIN ENDOTHELIAL CELL; BIOAVAILABILITY; CELL CULTURE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CHEMISTRY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; STRUCTURE ACTIVITY RELATION;

BIOLOGICAL AVAILABILITY; CALCIUM; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAGNESIUM; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; PYRROLIDONECARBOXYLIC ACID; SALTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901003102     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2014.0359     Document Type: Article

References (47)

1. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5: i3-14.
2. Alfrey AC, Miller NL. Bone magnesium pools in uremia. J Clin Invest 1973; 52: 3019-27.
3. Alfrey AC, Miller NL, Trow R. Effect of age and magnesium depletion on bone magnesium pools in rats. J Clin Invest 1974; 54: 1074-81.
4. Nakaya Y, Uehara M, Katsumata S, Suzuki K, Sakai K, Ohnishi R, Akiyama S, Ohta A. The frequency of magnesium consumption directly influences its serum concentration and the amount of elutable bone magnesium in rats. Magnes Res 2010; 23: 48-56.
5. Pironi L, Malucelli E, Guidetti M, Lanzoni E, Farruggia G, Pinna AD, Barbiroli B, Iotti S. The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure. Magnes Res 2009; 22: 37-43.
6. Spiegel DM. Magnesium in chronic kidney disease: unanswered questions. Blood Purif 2011; 31: 172-6.
7. Quamme GA, de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front Biosci 2000; 5: D694-711.
8. Kerstan D, Quamme G. Physiology and pathophysiology of intestinal absorption of magnesium. In: Calcium in Internal Medicine, edited by Massry SG, Morii H, and Nishizawa Y. 2002; Springer-Verlag, London, 171-83.
9. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003; 24: 47-66.
10. Saris NEL, Mervaala E, Karppanen H, Khavaja JA, Lewenstam A. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
11. Romani AMP. Magnesium homeostasis in mammalian cells. Met Ions Life Sci 2013; 12: 69-118.
12. Kisters K. What is the correct magnesium supplement? Magnes Res 2013; 26: 41-2.
13. Shechter M. Reply to the letter: "What is the correct magnesium supplement?" By Kister. Magnes Res 2013; 26: 42-5.
14. Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol JC, Mazur A, Rayssiguier Y. Study of magnesium bioavailability from ten organic and inorganicMgsalts in Mg-depleted rats using a stable isotope approach. Magnes Res 2005; 18: 215-23.
15. Slutsky I, Abumaria N, Wu L, Huang C, Zang L, Li B, Zhao X, Govindarajan A, Zhao MG, Zhuo M, Tonegawa S, Liu G. Enhancement of learning and memory by elevating brain magnesium. Neuron 2009; 65: 165-77.
16. Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. AmJTher 2001; 8: 345-57.
17. Covington AK, Danish EY. Measurement of magnesium stability constant of biologically relevant ligands by simultaneous use of pH and ionselective electrodes. J Solution Chem 2009; 38: 1449-62.
18. Blaquiere C, Berton G. Speciation studies in relation of magnesium bioavailability. Formation of Mg(II) complexes with glutamate, aspartate, glycinate, lactate, pyroglutamate, pyridoxine and citrate, and appraisal of their potential significance towards magnesium gastrointestinal absorption. Inorg Chim Acta 1987; 125: 179-89.
19. Durlach J, Bara M, Theophanides T. A hint on pharmacological and toxicological differences between magnesium chloride and magnesium sulphate, or of scallops and men. Magnes Res 1996; 9: 217-9.
20. Wolf FI, Torsello A, Fasanella S, Cittadini A. Cell physiology of magnesium. Mol Asp Med 2003; 24: 11-26.
21. Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Arch. Biochem. Biophys 2007; 458: 90-102.
22. Wolf FI, Trapani V, Simonacci M, Boninsegna A, Mazur A, Maier JA. Magnesium deficiency affects mammary epithelial cell proliferation: involvement of oxidative stress. Nutr Cancer 2009; 61: 131-6.
23. Wolf FI, Trapani V, Cittadini A. Magnesium and the control of cell proliferation: looking for a needle in a haystack. Magnes Res 2008; 21: 83-91.
24. Castiglioni S, Leidi M, Carpanese E, Maier JAM. Extracellular magnesium and in vitro cell differentiation: different behaviour of different cells. Magnes Res 2013; 26: 24-31.
25. Nusse M, Beisker W, Hoffmann C, Tarnok A. flow cytometric analysis of G1-and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements. Cytometry 1990; 11: 813-21.
26. Marraccini C, Farruggia G, Lombardo M, Prodi L, Sgarzi M, Trapani V, Trombini C, Zaccheroni N, Wolf FI, Iotti S. Diaza-18-crown-6 hydroxyquinoline derivatives as flexible tools for the assessment and imaging of total intracellular magnesium. Chem Sci 2012; 3: 727-34.
27. Sargenti A, Farruggia G, Malucelli E, Cappadone C, Merolle M, Marraccini M, Andreani G, Prodi L, Zaccheroni N, Sgarzi M, Trombini C, Lombardo M, Iotti S. A novel fluorescent chemosensor allows the assessment of intracellular total magnesium in small samples. Analyst 2014; 139: 1201-7.
28. Malgaroli A, Milani D, Meldolesi J, Pozzan T. Fura-2/AM measurement of cytosolic free Ca in monolayers and suspensions of various types of animal cells. J Cell Biol 1987; 105: 2145-55.
29. Sun Y, Selvaraj S, Varma A, Derry S, Sahmoun A, Singh BB. Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels. J Biol Chem 2013; 288: 255-63.
30. Hazelton B, Mitchell B, Tupper J. Calcium, magnesium, and growth control in the WI-38 human fibroblast cell. J Cell Biol 1979; 83: 487-98.
31. Anghileri LJ. Magnesium, calcium and cancer. Magnes Res 2009; 22: 247-55.
32. Wolf FI, Fasanella S, Tedesco B, Torsello A, Sgambato A, Faraglia B, Palozza P, Boninsegna A, Cittadini A. Regulation of magnesium content during proliferation of mammary epithelial cells HC-11. Front Biosci 2004; 9: 2056-62.
33. Rubin H. Central roles of Mg2+ and MgATP2+ in the regulation of protein synthesis and cell proliferation: significance for neoplastic transformation. Adv Cancer Res 2005; 93: 1-58.
34. Banai S, Haggroth L, Epstein SE, Casscells W. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res 1990; 67: 645-50.
35. Watson RR, Preedy VR, Zibadi S (Eds). Magnesium in human health and disease. 2013; Humana Press, New York.
36. Mauskop A, Varughese J. Why all migraine patients should be treated with magnesium. J Neural Transm 2012; 119: 575-9.
37. Leidi M, Dellera F, Mariotti M, Maier JAM. High magnesium inhibits human osteoblast differentiation in vitro. Magnes Res 2011; 24: 1-6.
38. Maier JA, Bernardini D, Rayssiguier Y, Mazur A. High concentrations of magnesium modulate vascular endothelial behaviour in vitro. Biochim Biophys Acta 2004; 1689: 6-12.
39. Ikari A, Atomi K, Kinjo K, Sasaki Y, Sugatani J. Magnesium deprivation inhibits a MEK-ERK cascade and cell proliferation in renal epithelial Madin-Darby canine kidney cells. Life Sci 2010; 86: 766-73.
40. Leidi M, Dellera F, Mariotti M, Banfi G, Crapanzano C, Albisetti W, Maier JA. Nitric oxide mediates low magnesium inhibition of osteoblast-like cell proliferation. J Nutr Biochem 2012; 23: 1224-9.
41. Abed E, Moreau R. Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor. Am J Physiol Cell Physiol 2009; 297: C360-8.
42. Abed E, Labelle D, Martineau C, Loghin A, Moreau R. Expression of transient receptor potential (TRP) channels in human and murine osteoblast-like cells. Mol Membr Biol 2009; 26: 146-58.
43. Nestler A, Sponder G, Rutschmann K, Mastrototaro L, Weise C, Vormann J, Schweigel Röntgen M, Kolisek M. Nature of SLC41A1 complexes: report on the split-ubiquitin yeast two hybrid assay. Magnes Res 2013; 26: 56-66.
44. Pautke C, Schieker M, Tischer T, Kolk A, Neth P, Mutschler W, Milz S. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res 2004; 24: 3743-8.
45. Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M, Squire JA. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet 2003; 144: 91-9.
46. Bac P, Pages N, Herrenknecht C, Teste JF. Inhibition of mouse-killing behaviour in magnesiumdeficient rats: effects of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride. Magnes Res 1995; 8: 37-45.
47. Raghupathy R, Billett HH. Promising therapies in sickle cell disease. Cardiovasc Hematol Disord Drug Targets 2009; 9: 1-8.